⌘K

Login Start Free

Home/Filings/4/0000899243-22-012144

4//SEC Filing

Vukovic Vojo 4

Accession 0000899243-22-012144

CIK 0001420565other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 7:43 PM ET

Size

5.4 KB

Accession

0000899243-22-012144

Insider Transaction Report

Form 4

Period: 2022-03-22

AILERON THERAPEUTICS INCALRN

SVP, Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2022-03-22+150,000→ 150,000 total
Exercise: $0.44Exp: 2032-03-21→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1

filerCIK 0001466794

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 7:43 PM ET
Size: 5.4 KB

View on SEC.gov